Literature DB >> 6538102

Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer.

B S Thomas, R D Bulbrook, M J Russell, J L Hayward, R R Millis.   

Abstract

The amounts of urinary androsterone and etiocholanolone are highly correlated with recurrence rates in patients with early breast cancer after treatment by mastectomy. A more efficient means of predicting the clinical course of the disease is obtained by using a ratio of these compounds to the amounts of individual 17-hydroxycorticosteroids in the urine. For instance, the ratio of androsterone to alpha-cortolone is particularly effective in identifying women with a high rate of recurrence, and this is largely independent of pathological stage and tumor grade.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538102     DOI: 10.1007/bf01806985

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY.

Authors:  R D BULBROOK; J L HAYWARD; B S THOMAS
Journal:  Lancet       Date:  1964-05-02       Impact factor: 79.321

2.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.

Authors:  R D BULBROOK; F C GREENWOOD; J L HAYWARD
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

3.  Automated urinary steroid profiles by capillary column gas-liquid chromatography and a computing integrator.

Authors:  V Fantl; C H Gray
Journal:  Clin Chim Acta       Date:  1977-08-15       Impact factor: 3.786

4.  Hormonal status of breast cancer. III. Further analysis of ovarian-adrenal dysfunction.

Authors:  M Kodama; T Kodama; S Miura; M Yoshida
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

5.  Urinary 17-ketosteroid excretion of women with advanced breast cancer.

Authors:  S Kumaoka; N Sakauchi; O Abe; M Kusama; O Takatani
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

6.  Adrenal function in breast cancer: biogenesis of androgens and cortisol by the human adrenal gland in vivo.

Authors:  N Deshpande; V Jensen; P Carson; T W Doouss; R D Bulbrook
Journal:  J Endocrinol       Date:  1970-06       Impact factor: 4.286

7.  Urinary androgen metabolites and recurrence rates in early breast cancer.

Authors:  B S Thomas; R D Bulbrook; J L Hayward; R R Millis
Journal:  Eur J Cancer Clin Oncol       Date:  1982-05

8.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  9 in total
  1 in total

1.  The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids.

Authors:  Lauren C Houghton; Renata E Howland; Ying Wei; Xinran Ma; Rebecca D Kehm; Wendy K Chung; Jeanine M Genkinger; Regina M Santella; Michaela F Hartmann; Stefan A Wudy; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-30       Impact factor: 4.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.